LIXTE Adds Northwestern University's Lurie Cancer Center as Second Site in Ongoing Clinical Trial for Ovarian Clear Cell Cancer
Express News | Lixte Adds NorthWestern University’s Lurie Cancer Center as Second Site in Ongoing Clinical Trial for Ovarian Clear Cell Cancer
Lixte Biotechnology Closes $1.1 Million Direct Offering
Express News | Lixte Biotechnology Announces $1.05 Million Registered Direct Offering Priced at-the-Market Under Nasdaq Rules
LIXTE Biotechnology Announces $1.05 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Why Lattice Semiconductor Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
LIXTE Biotechnology Holdings, Inc. Withdraws Registration Statement for Proposed Public Offering
LIXTE Biotechnology Submits Request for Withdrawal of Form S-1 Registration Statement
Express News | Lixte Biotechnology Submits Request for Withdrawal of Form S-1 Registration Statement
Express News | Lixte Biotechnology Holdings - on Dec 23, Eric Forman Resigns as Vp and COO of Lixte Biotech Effective as of Dec 31
10-Q: Q3 2024 Earnings Report
Trending Stocks Today | GlycoMimetics Shoots up 227.4%
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Top Premarket Gainers
Express News | Shuttle Pharmaceuticals shares surge 81% after it finalized agreements with all six planned site enrollment locations.
Trending Stocks Today | Lixte Biotechnology Surges 84.73% Pre-Market
Lixte Biotechnology Files to Sell Units, No Amount Given
Investor Summit August 2024 Presentations Now Accessible for On-Demand Viewing
Express News | LIXTE Biotechnology Receives USPTO Notice Of Allowance For Patent On Combining LB-100 With Cancer Immunotherapies, Strengthening Its Intellectual Property Portfolio And Advancing Cancer Treatment Trials
Why Nordstrom Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket